What We Do
Pharmaceutical patent counsel for portfolio management and strategy
A practical model for outside in-house patent counsel
Barash Law provides pharmaceutical patent counsel as an external partner that functions like in-house. Companies trust us to build and manage a patent portfolio that fits the drug pipeline and investor expectations.
Portfolio management that matches development
We create a clear roadmap for intellectual property protection while effectively managing patient prosecution if needed.
Strategy for startups and growing teams
Early-stage ventures need pharmaceutical patent counsel that can set direction fast. We help founders prioritize what to file now, what to defer, and how to frame claims that support near-term goals. As the team grows, we scale the cadence and refine strategy so the portfolio stays aligned with development.
Coordination across filings, offices, and data
Outside in-house counsel relies on clear communication. Barash Law works directly with scientists, analyzes the right data to develop robust IP. We coordinate with trusted firms and keep everything synchronized so the portfolio reads as one coherent strategy.
Solid form integration where it adds value
When screening reveals polymorphs, salts, cocrystals, or amorphous forms, we evaluate which results merit solid form patents and how to present characterization data.
Agreements, diligence, and investor alignment
As part of the outside counsel relationship, Barash Law supports research and collaboration agreements, licenses and other strategic contracts. For fundraising or M&A, we prepare concise materials that explain the portfolio to make diligence straightforward for both sides.
Learn more
Why teams choose Barash Law
Clients select Barash Law for a blend of chemistry depth, pharmaceutical focus, and a practical, education-driven style. You work with a patent attorney who understands how to communicate IP value to executive teams and investors. The result is counsel that moves programs forward and keeps your portfolio usable in real decisions.
Let's Talk